FTSE 100: Banks and miners lead blue-chip fallers as traders eye Greece Evraz, the Russian steel producer, led the laggards in morning trading, losing 4.5pc as miners tracked a retreat in metal prices. Vedanta Resources also dropped 2.8pc, Eurasian Natural Resources Corporation shed 2pc and Antofagasta fell 1.8pc. Amongst the banks, Barclays shed 2pc while Standard Chartered Bank lost 2pc and Royal Bank of Scotland eased 2pc. The latter's fall came as the bank's chief executive, Stephen Hester, decided to waive a £1m share bonus. Analysts at Shore Capital were concerned by the move, saying: "We reiterate our view that Mr Hester and his team have done an excellent job in driving the bank towards stability during the past 12 months and that the ongoing politicisation of contractually owed bonuses can only serve to increase the risk that management will ultimately decide to leave, severely hampering the prospects of a further recovery." "This is one of a number of reasons why we think it is still too early to take a positive stance on Royal Bank of Scotland shares," they added, keeping their "hold" rating. But Bruce Packard, an analyst at Seymour Pierce, argued: "There is clearly a lot of politics in this, but from a minority shareholder investment case we believe this is a positive. Any attempt by politicians to address the 'principal agent problem' in banking and more clearly align incentives with actual share price performance (RBS shares down by a third in the last year) ought to be taken as good news for owners of the business. With banks and miners on the wane, the FTSE 100 dropped 30 points to 5704 as dealers were troubled by the fact that Greece has not yet finalised a debt-swap deal with private creditors. European Union leaders are gathering today for their first summit in 2012 to put the finishing touches on a deficit-control treaty and endorse the statutes of a €500bn rescue fund to be set up this year. Greece and its private bondholders said on January 28 they expect to complete a deal this week after creditors signaled they would accept European demands for a bigger cut in their debt holdings. A smattering of defensives were gaining ground, with GlaxoSmithKline up 1.3pc, its stablemate AstraZeneca up 0.4pc, and telecoms giant Vodafone rising 0.5pc. Microchip designer, ARM Holdings, gained just over 1pc as Nomura raised its price target to 580p from 570p.